{"id":"topical-hemostat","safety":{"commonSideEffects":[{"rate":null,"effect":"Skin irritation"}]},"_chembl":{"chemblId":"CHEMBL2108694","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"They typically contain a combination of ingredients such as collagen, gelatin, or other substances that help to constrict blood vessels and promote platelet aggregation, ultimately leading to the formation of a stable clot. This process is essential for preventing excessive blood loss and promoting wound healing.","oneSentence":"Topical hemostats work by physically obstructing blood flow to a wound site, thereby facilitating clotting and stopping bleeding.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:39:24.592Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control of bleeding during surgery"}]},"trialDetails":[{"nctId":"NCT04953949","phase":"NA","title":"IEIK13 For Neurosurgery","status":"COMPLETED","sponsor":"3-D Matrix Europe SAS","startDate":"2021-08-06","conditions":"Oozing (Hemorrhage) During Intracranial Procedures","enrollment":80},{"nctId":"NCT05984264","phase":"PHASE4","title":"Efficacy of Topical Lidocaine/Prilocaine in Pain Management in Pleurocentesis","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-01-01","conditions":"Pleural Effusion","enrollment":118},{"nctId":"NCT03762200","phase":"NA","title":"SURGICEL® Powder in Controlling Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding in Adult Subjects","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2018-11-26","conditions":"Hemorrhage","enrollment":103},{"nctId":"NCT03783039","phase":"NA","title":"The SURGICEL® Powder Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding (China Study)","status":"COMPLETED","sponsor":"Ethicon, LLC","startDate":"2019-01-15","conditions":"Hemorrhage","enrollment":234},{"nctId":"NCT03165149","phase":"PHASE2, PHASE3","title":"Effect of a Topical Ketamine on Acute and Chronic Pain, Dose Finding","status":"COMPLETED","sponsor":"Assiut University","startDate":"2017-06-01","conditions":"Breast Cancer","enrollment":90},{"nctId":"NCT02117349","phase":"PHASE2","title":"Topical Raplixa for Surgical Bleeding in Children","status":"TERMINATED","sponsor":"Mallinckrodt","startDate":"2014-12-04","conditions":"Surgical Bleeding","enrollment":55},{"nctId":"NCT01230931","phase":"NA","title":"Hemostasis in Kocher-Langenbeck Approaches for Acetabular Surgery Using a Topical Surgical Hemostat (Vitagel)","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2010-10","conditions":"Fracture Fixation, Intra-Articular Fractures, Acetabulum","enrollment":26},{"nctId":"NCT02704104","phase":"NA","title":"Safety and Performance Evaluation of the Topical Hemostatic Device (AC5™) Following Excision of Skin Lesions","status":"COMPLETED","sponsor":"Arch Therapeutics","startDate":"2016-02","conditions":"Skin Neoplasms","enrollment":46},{"nctId":"NCT01681030","phase":"PHASE2","title":"The Fibrin Pad Cardiovascular Study","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2012-08-01","conditions":"Cardiovascular Disease","enrollment":42},{"nctId":"NCT01902459","phase":"PHASE4","title":"EVARREST™ Fibrin Sealant Patch Post-Market Study","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2013-07-01","conditions":"Hemorrhage, Soft Tissue Bleeding","enrollment":150},{"nctId":"NCT02040428","phase":"PHASE3","title":"The Fibrin Pad CV Phase III Study","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2014-01-01","conditions":"Cardiovascular Disease","enrollment":156},{"nctId":"NCT03156387","phase":"NA","title":"Clinical Efficacy of Frenectomies Using Diode Laser Versus Conventional Techniques","status":"COMPLETED","sponsor":"T.C. Dumlupınar Üniversitesi","startDate":"2015-02-01","conditions":"High Frenum Attachment","enrollment":28},{"nctId":"NCT01500135","phase":"PHASE3","title":"Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery","status":"COMPLETED","sponsor":"Takeda","startDate":"2012-03","conditions":"Bleeding","enrollment":150},{"nctId":"NCT01993888","phase":"PHASE3","title":"The EVARREST® Fibrin Sealant Patch Liver Study","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2013-10","conditions":"Hemorrhage","enrollment":102},{"nctId":"NCT02596282","phase":"PHASE2, PHASE3","title":"Enhanced Provision of Male Circumcision (MC) for HIV Prevention, Rakai, Uganda","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2014-10","conditions":"Neonatal Male Circumcision","enrollment":501},{"nctId":"NCT01879475","phase":"NA","title":"Safety and Performance of 032-11 Haemostat in Cardiac and Thoracic Aortic Surgery","status":"UNKNOWN","sponsor":"Medtrade","startDate":"2013-06","conditions":"C.Surgical Procedure; Cardiac, Haemorrhage.","enrollment":200},{"nctId":"NCT01639833","phase":"NA","title":"A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery","status":"COMPLETED","sponsor":"Medtronic - MITG","startDate":"2012-08","conditions":"Cardiac Surgical Procedures, Hemorrhage","enrollment":90},{"nctId":"NCT01324349","phase":"NA","title":"Comparison of the Hemostatic Patch to Fibrin Sealant (TachoSil®) in Subjects Undergoing Hepatic Surgery","status":"COMPLETED","sponsor":"Medtronic - MITG","startDate":"2011-02","conditions":"Liver Disease","enrollment":50},{"nctId":"NCT01719172","phase":"NA","title":"A Prospective, Multi-Center, Single-Arm Study of the Veriset™ Hemostatic Patch in Controlling Bleeding in Soft Tissue","status":"COMPLETED","sponsor":"Medtronic - MITG","startDate":"2012-09","conditions":"Non-emergent, Soft Tissue Procedures, Performed Via an Open Approach","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":32,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Topical hemostat","genericName":"Topical hemostat","companyName":"Ethicon, Inc.","companyId":"ethicon-inc","modality":"Biologic","firstApprovalDate":"","aiSummary":"Topical hemostats work by physically obstructing blood flow to a wound site, thereby facilitating clotting and stopping bleeding. Used for Control of bleeding during surgery.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":2},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}